SCHEMBL13152003

SCHEMBL13152003

CCOc1ccc2c(N)c(-c3ccc(NC(=O)OC(C)C)cc3)n(C3CC3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
ACACB O00763 1/20 0.39
TP53 P04637 2/20 0.38
ALDH1A1 P00352 3/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
MMP14 P50281 1/20 0.37
PLAU P00749 2/20 0.37
POLB P06746 1/20 0.37
F2 P00734 1/20 0.37
F10 P00742 1/20 0.37
PLAT P00750 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10097368 0.96 RAB9A (0.39) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL13152677 0.96 RAB9A (0.39) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL13151986 0.92 NPC1 (0.51) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL13051587 0.92 RAB9A (0.37) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL12489610 0.91 MEN1 (0.38) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL10097555 0.91 NPC1 (0.40) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL10097435 0.91 MEN1 (0.38) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL14467126 0.91 MEN1 (0.39) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL14466312 0.91 NPC1 (0.38) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL13215084 0.90 NPC1 (0.39) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118009-A1 HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS PTC THERAPEUTICS, INC. (US) 2010-10-14 WO disclosed
WO-2007084435-A2 METHODS FOR TREATING HEPATITIS C PTC THERAPEUTICS, INC. (US) 2007-07-26 WO disclosed